ATE245189T1 - Zellsystem mit einer spezifischen wechselwirkung von peptid-bindenden paaren - Google Patents

Zellsystem mit einer spezifischen wechselwirkung von peptid-bindenden paaren

Info

Publication number
ATE245189T1
ATE245189T1 AT95920689T AT95920689T ATE245189T1 AT E245189 T1 ATE245189 T1 AT E245189T1 AT 95920689 T AT95920689 T AT 95920689T AT 95920689 T AT95920689 T AT 95920689T AT E245189 T1 ATE245189 T1 AT E245189T1
Authority
AT
Austria
Prior art keywords
peptide
transcriptional activation
fusion protein
protein
host cell
Prior art date
Application number
AT95920689T
Other languages
English (en)
Inventor
Kathleen H Young
Bradley A Ozenberger
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE245189T1 publication Critical patent/ATE245189T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95920689T 1994-06-14 1995-05-31 Zellsystem mit einer spezifischen wechselwirkung von peptid-bindenden paaren ATE245189T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/259,609 US5989808A (en) 1994-06-14 1994-06-14 Identification of compounds affecting specific interaction of peptide binding pairs
PCT/US1995/006895 WO1995034646A1 (en) 1994-06-14 1995-05-31 Novel cell systems having specific interaction of peptide binding pairs

Publications (1)

Publication Number Publication Date
ATE245189T1 true ATE245189T1 (de) 2003-08-15

Family

ID=22985626

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95920689T ATE245189T1 (de) 1994-06-14 1995-05-31 Zellsystem mit einer spezifischen wechselwirkung von peptid-bindenden paaren

Country Status (18)

Country Link
US (3) US5989808A (de)
EP (1) EP0765389B1 (de)
AT (1) ATE245189T1 (de)
AU (1) AU706173B2 (de)
CA (1) CA2195083A1 (de)
DE (1) DE69531302T2 (de)
DK (1) DK0765389T3 (de)
ES (1) ES2202366T3 (de)
GE (1) GEP20022619B (de)
IL (1) IL114118A0 (de)
LT (1) LT4230B (de)
LV (1) LV11906B (de)
NZ (1) NZ287372A (de)
PT (1) PT765389E (de)
RU (1) RU2208646C2 (de)
SI (1) SI9520073B (de)
WO (1) WO1995034646A1 (de)
ZA (1) ZA954892B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226761B2 (en) * 1992-11-05 2007-06-05 Danisco Sweeteners Oy Manufacture of five-carbon sugars and sugar alcohols
US6972193B1 (en) * 1993-02-12 2005-12-06 Board Of Trustees Of Leland Stanford Junior University Regulated transcription of targeted genes and other biological events
US6891021B2 (en) 1993-02-12 2005-05-10 Board Of Trustees Of The Leland Stanford Junior University Regulated apoptosis
US6770446B1 (en) * 1994-06-14 2004-08-03 Wyeth Cell systems having specific interaction of peptide binding pairs
US5610015A (en) * 1995-03-23 1997-03-11 Wisconsin Alumni Research Foundation System to detect protein-RNA interactions
DE69636866D1 (en) * 1995-04-11 2007-03-15 Gen Hospital Corp Reverse "two-hybrid"-systeme
US5837844A (en) * 1995-06-07 1998-11-17 Biogen, Inc. CAIP-like gene family
US6423824B1 (en) 1995-06-07 2002-07-23 Biogen, Inc. CAIP-like gene family
US6171800B1 (en) 1995-06-07 2001-01-09 Biogen, Inc. Method of making and binding CAIP polypeptides
DE29724617U1 (de) * 1996-04-26 2002-06-13 Massachusetts Inst Technology Drei-Hybrid-Kit zur Molekülauswahl
DE69715621T2 (de) * 1996-04-26 2003-05-22 Massachusetts Inst Technology Drei hybriden screening test
US6696251B1 (en) 1996-05-31 2004-02-24 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
AU6342696A (en) * 1996-06-27 1998-01-14 Biogen, Inc. The caip-like gene family
FR2761697B1 (fr) * 1997-04-03 1999-05-28 Inst Nat Sante Rech Med Methodes de detection d'interactions entre plusieurs proteines
DE19715683C2 (de) * 1997-04-15 1999-11-11 Max Planck Gesellschaft Neue Reportervektoren für One-Hybrid und Two-Hybrid Systeme
US7005295B1 (en) 1997-04-16 2006-02-28 Wyeth β-amyloid peptide-binding proteins and polynucleotides encoding the same
US6787319B2 (en) 1997-04-16 2004-09-07 American Home Products Corp. β-amyloid peptide-binding proteins and polynucleotides encoding the same
AU6969998A (en) 1997-04-25 1998-11-24 American Home Products Corporation Neuronal mort1 isoforms
US6479653B1 (en) 1997-08-26 2002-11-12 Ariad Gene Therapeutics, Inc. Compositions and method for regulation of transcription
JP4296608B2 (ja) * 1997-08-27 2009-07-15 田辺三菱製薬株式会社 Ｐｐａｒのアゴニスト及びアンタゴニストのスクリーニング方法
EP1149920A1 (de) * 1997-10-15 2001-10-31 Diversa, Inc. Screening fÜr neue Verbindungen, die biologische Interaktionen regulieren
EP1029076A4 (de) * 1997-10-15 2002-03-06 Diversa Inc Screening für neue verbindungen, die biologische interaktionen regulieren
US6261842B1 (en) 1997-10-23 2001-07-17 Wisconsin Alumni Research Foundation Microorganism genomics, compositions and methods related thereto
CA2309763A1 (en) * 1997-11-14 1999-05-27 Roche Diagnostics Corporation Variable region fusion peptides that form effector complexes in the presence of antigen
CA2317816C (en) 1998-01-09 2009-02-17 Tvw Telethon Institute For Child Health Research Peptide detection method
EP0974649A1 (de) * 1998-06-22 2000-01-26 Universität Zürich Screening-System
US7166475B2 (en) 1999-02-26 2007-01-23 Cyclacel Ltd. Compositions and methods for monitoring the modification state of a pair of polypeptides
GB9907687D0 (en) * 1999-04-01 1999-05-26 Kudos Pharm Ltd Assays methods and means
JP2002541863A (ja) 1999-04-21 2002-12-10 ワイス Ｎ−型イオンチャンネル不活性化のモジュレーターを同定する方法
BR0110214A (pt) * 2000-04-24 2003-01-21 Wyeth Corp Célula de levedura e métodos de detecção da interação de um primeiro peptìdio com um segundo peptìdio de um par de ligação de peptìdios, de determinação da interação de uma amostra de teste com um primeiro ou um segundo peptìdios de um par de ligação de peptìdios e de detecção simultânea da interação de dois pares de ligação de peptìdios diferentes
CN1564869A (zh) 2000-08-25 2005-01-12 巴斯福种植科学有限公司 编码新型异戊二烯基蛋白酶的植物多核苷酸
WO2002046400A2 (en) * 2000-12-08 2002-06-13 The Board Of Trustees Of The University Of Illinois Mutated class ii major histocompatibility proteins
EP1534819B1 (de) 2002-08-21 2009-12-09 Revivicor, Inc. Schweine ohne jegliche expression funktioneller alpha-1,3-galactosyltransferase
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US7285269B2 (en) 2002-12-02 2007-10-23 Amgen Fremont, Inc. Antibodies directed to tumor necrosis factor
WO2005049804A2 (en) * 2003-11-17 2005-06-02 Georgia Tech Research Corporation Engineering enzymes through genetic selection
EP1544307A1 (de) * 2003-12-18 2005-06-22 AXXAM S.r.l. Chimärer LAC9 Rezeptor und dessen Verwendungen
EP2412816B1 (de) 2004-07-26 2014-12-03 Pfenex Inc. Verfahren zur verbesserten Proteinexpression durch Strain-Engineering
EP3138403A1 (de) 2005-08-09 2017-03-08 Revivicor, Inc. Ctla4-ig exprimierende transgene huftiere und verwendungen davon
CN101365945A (zh) * 2006-02-07 2009-02-11 惠氏公司 用于鉴别调节诺里蛋白、诺里蛋白模拟物的药剂的物质和方法以及由此鉴别出的药剂
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
MX2009011523A (es) 2007-04-27 2009-11-09 Dow Global Technologies Inc Metodo para clasificar rapidamente huespedes microbianos para identificar ciertas cepas con rendimiento y/o calidad mejorados en la expresion de proteinas heterologas.
CN101131363B (zh) * 2007-09-30 2010-12-01 南京大学 一种基于酵母三杂交的小分子化合物检测方法
CA2980316A1 (en) 2015-03-24 2016-09-29 Osiris Therapeutics, Inc. Compositions comprising meniscal tissues and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5322801A (en) * 1990-04-19 1994-06-21 The General Hospital Corporation Protein partner screening assays and uses thereof
JP3537141B2 (ja) * 1992-10-30 2004-06-14 ザ ゼネラル ホスピタル コーポレーション 新種蛋白質分離のための相互作用を用いる補捉システム
US5512473A (en) * 1993-01-29 1996-04-30 Brent; Roger Max-interacting proteins and related molecules and methods
US5582995A (en) * 1993-06-11 1996-12-10 The General Hospital Corporation Methods of screening for compounds which inhibit the direct binding of Ras to Raf
CA2180271A1 (en) * 1993-12-30 1995-07-06 Ronald M. Evans Novel uses for gal4-receptor constructs
ES2146749T3 (es) * 1994-01-21 2000-08-16 Icos Corp Materiales y metodos en relacion con proteinas que interaccionan con la caseina quinasa i.
US5525490A (en) * 1994-03-29 1996-06-11 Onyx Pharmaceuticals, Inc. Reverse two-hybrid method
US5691147A (en) * 1994-06-02 1997-11-25 Mitotix, Inc. CDK4 binding assay

Also Published As

Publication number Publication date
ES2202366T3 (es) 2004-04-01
DE69531302D1 (de) 2003-08-21
IL114118A0 (en) 1995-10-31
EP0765389B1 (de) 2003-07-16
LV11906B (en) 1998-06-20
RU2208646C2 (ru) 2003-07-20
LT97004A (en) 1997-07-25
SI9520073A (sl) 1998-02-28
DE69531302T2 (de) 2004-04-22
SI9520073B (sl) 2004-06-30
AU706173B2 (en) 1999-06-10
US6284519B1 (en) 2001-09-04
GEP20022619B (en) 2002-01-25
LV11906A (lv) 1997-12-20
US6251602B1 (en) 2001-06-26
NZ287372A (en) 1997-11-24
PT765389E (pt) 2003-11-28
ZA954892B (en) 1996-01-30
CA2195083A1 (en) 1995-12-21
WO1995034646A1 (en) 1995-12-21
AU2606695A (en) 1996-01-05
US5989808A (en) 1999-11-23
EP0765389A1 (de) 1997-04-02
LT4230B (en) 1997-10-27
DK0765389T3 (da) 2003-10-27

Similar Documents

Publication Publication Date Title
ATE245189T1 (de) Zellsystem mit einer spezifischen wechselwirkung von peptid-bindenden paaren
Matsuda et al. Distribution of cold-insoluble globulin in plasma and tissues.
ATE335078T1 (de) Überexpression von säugetier- und virusproteinen
ATE254136T1 (de) Interaktions-fullensysteme zum nachweis von protein-interaktionen
DK61595A (da) Rekombinant DNA-molekyler, værtscelletransformering dermed, værtsceller indeholdende disse samt fremgangsmåde til fremstilling af et polypeptid af IFN-alfa-typen
ATE238550T1 (de) Markierung und auswahl von molekülen
ATE389666T1 (de) Hohe expressionsrate von proteinen
NZ332598A (en) Human BAS-1 protein, and use as an antagonist for modulating physiology or development of a cell
DE69715621D1 (de) Drei hybriden screening test
FI965220A (fi) Ei-toksinen, ei-toksigeeninen, ei-patogeeninen Fusarium-ilmentämissysteemi ja siinä käytettävät promootterit ja terminaattorit
DE69131580D1 (de) GDF-1 und UOG1 Proteine
ES8602119A1 (es) Metodo para preparar inmunoglobulinas en celulas hospedantes recombinantes
NO20020861L (no) Nye B7-4-molekyler og anvendelser derav
ES2064355T3 (es) Procedimiento para cultivar celulas recombinantes.
ATE198491T1 (de) System zur expression von heterologen antigenen als fusionsproteine
DK1032660T3 (da) Fremgangsmåde til identivicering af bindingsstedsdominans som bevarer evnen til at binde til en epitop
DE68905633D1 (de) Markierer der t-zelle aktivierung.
DE69632827D1 (de) Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen
WO1999043808A8 (en) Human c-maf compositions and methods of use thereof
FI972457A (fi) FAS/APO1-reseptorien toiminnan modulaattorit
NO962084L (no) DNA sekvens som koder for en BMP reseptor
PT625157E (pt) Epitopes p1a1 e p1a2 da gpiiia da plaqueta sua preparacao e utilizacao
NO922421L (no) Collagenbindende protein, samt fremstilling derav
Traub et al. Occurrence in various mammalian cells and tissues of the Ca 2+ activated protease specific for the intermediate-sized filament proteins vimentin and desmin.
ATE346919T1 (de) Nebenhoden-spezifisches rezeptorprotein und dessen verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0765389

Country of ref document: EP

REN Ceased due to non-payment of the annual fee